Senomyx, Inc.

Radionetics Oncology , a three-year-old start-up that has raised $82.5m to date, landed a sweet deal with Eli Lilly and Company , with the big pharma paying $140m up front for an exclusive right to b

Unusually, the VC investors in UK-based Microscience have announced they will pump a further £10 million into the vaccine developer as it tries to enter the lukewarm public markets with a summer IPO o

Sensational biotech As a founding member of the management team of Aurora Biosciences Corp. , a now public company with an ultra high-throughput screening platform for drug discovery, Paul Grayson w